Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|October 15, 2020
Being the Best Advocate for Yourself and Your Patients
Author(s)Cornel N. Stanciu, MD, MRO
COVID-19 is the most devastating pandemic in recent history, and it has taken a huge toll. Here are some tips to take into consideration when advocating for your safety and the safety of your patients.
Advertisement
Dr Stanciu is Addiction Section Editor for Psychiatric Times. He is Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine and Director of Addiction Services at New Hampshire Hospital, Concord, NH.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
Adjustment Disorder Is Hiding in Plain Sight
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5